Nano in Medicine & Health Lecture Series: Barcoded Nanoparticles for Precision Cancer Medicine: Effects of tumor type and patient sex on anticancer efficacy
|Dates:||10 March 2022|
|Times:||14:00 - 15:00|
|What is it:||Webinar|
|Organiser:||Faculty of Biology, Medicine and Health|
|Who is it for:||University staff, Adults, Current University students|
|Speaker:||Prof. Avi Schroeder|
On behalf of the Nanomedicine Lab at the Faculty of Biology, Medicine & Health and the Catalan Institute of Nanoscience and Nanotechnology (ICN2) we are delighted to invite you to our jointly organised NanoSeminars in Medicine & Health Lecture Series.
Our speaker, Prof. Avi Schroeder will be giving a seminar about Barcoded Nanoparticles for Precision Cancer Medicine. Prof Avi Schroeder is a tenured Associate Professor of Chemical Engineering at the Technion – Israel Institute of Technology, where he heads the Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies (https://www.schroederlab.com/ ).
Dr. Schroeder conducted his Postdoctoral studies at the Massachusetts Institute of Technology, and his PhD jointly at the Hebrew and Ben Gurion Universities. Avi is the recipient of more than 30 national and international awards, including named a KAVLI Fellow, the Intel Nanotechnology-, TEVA Pharmaceuticals-, and the Wolf Foundation Krill Awards.
Avi is the author of above 50-research papers inventor of 19 patents and co-founder of multiple startup companies based on these discoveries. Schroeder is a member of Israel Young National Academy of Sciences, Israel’s National Council for Civilian Research and Development, and the President of the Israel Institute of Chemical Engineers.
Medicine is taking its first steps towards patient-specific cancer care. Nanoparticles have many potential benefits for treating cancer, including the ability to transport complex molecular cargoes including siRNA and protein, as well as targeting to specific cell populations. The talk will discuss ‘barcoded nanoparticles’ that target sites of cancer where they perform a programmed therapeutic task. Specifically, liposomes that diagnose the tumor and metastasis for their sensitivity to different medications, providing patient-specific drug activity information that can be used to improve the medication choice. The talk will also describe how liposomes can be used for degrading the pancreatic stroma to allow subsequent drug penetration into pancreatic adenocarcinoma, and how nanoparticle’ biodistribution and anti-cancer efficacy is impacted by patient’ sex and more specifically, the menstrual cycle. The evolution of drug delivery systems into synthetic cells, programmed nanoparticles that have an autonomous capacity to synthesize diagnostic and therapeutic proteins inside the body, and their promise for treating cancer and immunotherapy, will be discussed. Find out more
This is an online meeting, register via Zoom
Prof. Avi Schroeder
Role: Associate Professor of Chemical Engineering
Organisation: Technion Israel Institute of Technology
Travel and Contact Information